Type 2 Diabetes and COVID-19 Related Mortality in Solapur: A Whole Population Study

Presently large-scale study concludes that there are many factors associated with an increased risk of COVID-19-related in-hospital death. Patients with comorbidities may be more susceptible to the COVID- 19 complications and may show compromised immune competency. The aim of the study is to find out increased relative and absolute risks of COVID-19, associated with Diabetes Mellitus in Solapur city. Study design is Cross sectional study. Study group included all patients with COVID -19 diabetic and non-diabetic patients in Solapur. It was observed that among all diabetic patients with COVID-19 fever was the most common initial symptoms; fever (100%) followed by cough (97.16%), Breathlessness (89.05%), dyspnea (9.81%),muscular soreness (6.22%) and chest distress(7.92%). In Diabetic with COVID-19, age distribution of the patients was in between 55-80 years, in non-diabetic COVID patients age group ranges 0-76 years and mortality rate observed in age group with 54-80 years. The present data showed higher mortality rate in patients of Diabetes Mellitus with COVID-19. Further it was observed that the mortality rate was higher in male (11.77 %) as compare to female (10.07 %.). Our study concludes that COVID-19 patients with Diabetes Mellitus are more prone for morbidity as compared with non-diabetic COVID patients. Diabetes Mellitus in COVID- 19 patients increases the susceptibility of complications with concomitant decrease immune system. The total number of COVID- 19 death recorded in Solapur included majority of the patients with Diabetes Mellitus as one of the responsible factor in worsening of the disease.